Oscar Health stock (NYSE: OSCR) has recently increased to over $16 after reports of a possible two-year extension of Obamacare subsidies, which may positively influence demand for health insurance via ...
Lululemon's growth story isn't as smooth as it once was, but the stock now trades at a valuation that seemed impossible just a few years ago. Today, that narrative looks very different. After several ...
Tesla remains a Sell due to an unsustainable, overinflated valuation with a P/E of 322.44 and weak recent growth metrics. Q3 earnings showed record revenue and energy storage growth, but automotive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results